With a market valuation of Rs. 30.34 crore, Shukra Pharmaceuticals Ltd. is a small cap company that operates in the pharmaceutical industry. Public Ltd Shukra Pharmaceuticals has well-known production facilities around the world. Since 2017, the company has been manufacturing pharmaceutical products such as tablets, capsules and parenteral products. The company’s board of directors has proposed a final dividend of 5% (0.50 rupees per share with a face value of 10 rupees), subject to shareholder approval at the annual general meeting which took place. follow-up, at their meeting held on May 28. , 2022.